Showing results (31-40 of 1,681) with videos related to
Sort By:
Pageof 169
Studies in Health Technology and Informatics|September 14, 2004
Cancer-related complementary and alternative medicine online: factors affecting information retrievalMuhammad Walji, Smitha Sagaram, Funda Meric-Bernstam, et al.International Journal of Medical Informatics|January 1, 2005
Instruments to assess the quality of health information on the World Wide Web: what can our patients actually use?Elmer V Bernstam, Dawn M Shelton, Muhammad Walji, et al.Studies in Health Technology and Informatics|September 14, 2004
Inter-observer agreement for quality measures applied to online health informationSmitha Sagaram, Muhammad Walji, Funda Meric-Bernstam, et al.Oncotarget|September 17, 2016
Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panelChan Shen, Funda Meric-Bernstam, Xiaoping Su, et al.Growth Factors (Chur, Switzerland)|December 17, 2008
Regulation and localization of ribosomal protein S6 kinase 1 isoformsDoyil Kim, Argun Akcakanat, Gopal Singh, et al.Oncotarget|December 21, 2019
Correction: FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cellsMing Zhao, Ming-Lei Zhuo, Xiaofeng Zheng, et al.Bioinformatics (Oxford, England)|June 30, 2012
PurityEst: estimating purity of human tumor samples using next-generation sequencing dataXiaoping Su, Li Zhang, Jianping Zhang, et al.Oncotarget|February 5, 2019
FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cellsMing Zhao, Ming-Lei Zhuo, Xiaofeng Zheng, et al.Expert Opinion on Investigational Drugs|August 14, 2018
Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapySiqing Fu, Yudong Wang, Khandan Keyomarsi, et al.Cell Genomics|February 13, 2023
Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencingJake Leighton, Min Hu, Emi Sei, et al.Pageof 169